10.23.23
Ortho Molecular Products announced that after 34 years as the company’s president, Aaron Bartz is transitioning to become the company’s chief strategic advisor, starting on Jan. 1, 2024.
Throughout his tenure, Bartz helped the company reach several significant milestones, and expand its presence in the healthcare practitioner channel, the company reported.
In his new role as chief strategic advisor, Bartz will continue to play a role in long-term strategic initiatives, and will be responsible for identifying new growth opportunities, fostering innovation, and ensuring the company remains at the forefront.
“We are immensely grateful for Aaron's outstanding leadership during his tenure as president of our company. His passion, dedication, work ethic, and unwavering commitment to our company's success have been instrumental in our growth and success over the years,” said Gary Powers, CEO of Ortho Molecular Products. “As chief strategic advisor, Aaron will continue to guide strategic decisions and market positioning, and we are confident that his leadership will help us achieve even greater heights.”
“I have been extremely blessed to spend the past 34 years working with some of the brightest people toward an extremely worthy vision: to transform the practice of medicine. Leading the day-to-day for the past 17 years, there have been many ups and occasional downs, but each day I felt like the luckiest person on the planet,” said Bartz. “We have accomplished remarkable things, and the brand is something that I could not be more proud of. I am looking forward to serving the organization in a new way.”
Throughout his tenure, Bartz helped the company reach several significant milestones, and expand its presence in the healthcare practitioner channel, the company reported.
In his new role as chief strategic advisor, Bartz will continue to play a role in long-term strategic initiatives, and will be responsible for identifying new growth opportunities, fostering innovation, and ensuring the company remains at the forefront.
“We are immensely grateful for Aaron's outstanding leadership during his tenure as president of our company. His passion, dedication, work ethic, and unwavering commitment to our company's success have been instrumental in our growth and success over the years,” said Gary Powers, CEO of Ortho Molecular Products. “As chief strategic advisor, Aaron will continue to guide strategic decisions and market positioning, and we are confident that his leadership will help us achieve even greater heights.”
“I have been extremely blessed to spend the past 34 years working with some of the brightest people toward an extremely worthy vision: to transform the practice of medicine. Leading the day-to-day for the past 17 years, there have been many ups and occasional downs, but each day I felt like the luckiest person on the planet,” said Bartz. “We have accomplished remarkable things, and the brand is something that I could not be more proud of. I am looking forward to serving the organization in a new way.”